In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela.

The Texas-based company has said it will investigate the results of its rheumatoid arthritis trial after finding ...

Knee arthritis could become easier to detect and diagnose thanks to a new test involving the lubricating fluid inside the ...

Using gabapentin with other arthritis treatments may help delay such procedures. While potentially useful for treating severe knee OA, there is no strong evidence that gabapentin can provide ...

Currently, the company is conducting research on cartilage regeneration, diabetes, arthritis, and other conditions.

The management of rheumatoid arthritis has seen tremendous changes over the past 25 years, since the increasing availability of biological disease-modifying antirheumatic drugs (DMARDs) with various ...

While biologic treatments do not cure rheumatoid arthritis (RA), they can slow its progression. They may also cause fewer side effects than other kinds of medications. Biological response ...

ResearchAyu was founded by Deepak Patil with the mission of discovering solutions for ailments often deemed incurable. The company is currently conducting extensive research on conditions such as ...

Genicular artery embolization (GAE) is a minimally invasive procedure shown to relieve knee osteoarthritis pain, improve ...

Highlights in psoriatic arthritis from ACR 2024 include results of methotrexate added to DMARD therapy, responses to bimekizumab, and improvements gained by upadacitinib after prior TNF inhibitor use.

Genetic markers may help predict response to TNF inhibitor therapy in rheumatoid arthritis, potentially leading to more ...

This year, the Arthritis Foundation celebrated 40 years of its festive Jingle Bell Run to raise funds to support research for ...